Title : CCCDTD5 recommendations on the deprescribing of cognitive enhancers in dementia - Herrmann_2022_Alzheimers.Dement.(N.Y)_8_e12099 |
Author(s) : Herrmann N , Ismail Z , Collins R , Desmarais P , Goodarzi Z , Henri-Bhargava A , Iaboni A , Kirkham J , Massoud F , Moser A , Silvius J , Watt J , Seitz D |
Ref : Alzheimers Dement (N Y) , 8 :e12099 , 2022 |
Abstract : |
PubMedSearch : Herrmann_2022_Alzheimers.Dement.(N.Y)_8_e12099 |
PubMedID: 35128025 |
Title : Pharmacological treatment of Alzheimer disease - Massoud_2011_Can.J.Psychiatry_56_579 |
Author(s) : Massoud F , Leger GC |
Ref : Can J Psychiatry , 56 :579 , 2011 |
Abstract : |
PubMedSearch : Massoud_2011_Can.J.Psychiatry_56_579 |
PubMedID: 22014690 |
Title : Switching cholinesterase inhibitors in older adults with dementia - Massoud_2011_Int.Psychogeriatr_23_372 |
Author(s) : Massoud F , Desmarais JE , Gauthier S |
Ref : Int Psychogeriatr , 23 :372 , 2011 |
Abstract : |
PubMedSearch : Massoud_2011_Int.Psychogeriatr_23_372 |
PubMedID: 21044399 |
Title : Update on the pharmacological treatment of Alzheimer's disease - Massoud_2010_Curr.Neuropharmacol_8_69 |
Author(s) : Massoud F , Gauthier S |
Ref : Curr Neuropharmacol , 8 :69 , 2010 |
Abstract : |
PubMedSearch : Massoud_2010_Curr.Neuropharmacol_8_69 |
PubMedID: 20808547 |
Title : Drug utilization review of cholinesterase inhibitors in Quebec - |
Author(s) : Massoud F , Dorais M , Charbonneau C , Lescrauwaet B , Boucher JM , LeLorier J |
Ref : Can Journal of Neurology Sci , 35 :508 , 2008 |
PubMedID: 18973072 |
Title : A retrospective study of cholinesterase inhibitors for Alzheimer's disease: cerebrovascular disease as a predictor of patient outcomes - Charbonneau_2008_Curr.Med.Res.Opin_24_3287 |
Author(s) : Charbonneau C , Massoud F , Dorais M , LeLorier J |
Ref : Curr Med Res Opin , 24 :3287 , 2008 |
Abstract : |
PubMedSearch : Charbonneau_2008_Curr.Med.Res.Opin_24_3287 |
PubMedID: 19032117 |